Information  X 
Enter a valid email address

Clarion Funding plc (96XN)

  Print      Mail a friend

Wednesday 06 January, 2021

Clarion Funding plc

Publication of supplement to the Offering Circular

RNS Number : 8036K
Clarion Funding plc
06 January 2021

6th January, 2021

Publication of a supplement to the Offering Circular

The following supplement to the Offering Circular has been approved by the Financial Conduct Authority and is available for viewing:

Supplement dated 6th January, 2021 (the Supplement) to the Offering Circular dated 31st March, 2020 (the Offering Circular) in respect of the £3,000,000,000 Secured Euro Medium Term Note Programme of Clarion Funding plc

To view the full document, please paste the following URL into the address bar of your browser.

A copy of the Supplement will also be submitted to the National Storage Mechanism and will shortly be available for inspection at:

For further information, please contact:

Clarion Funding plc

Gareth Francis, Director of Treasury and Corporate Finance

Level 6

6 More London Place

Tooley Street

London SE1 2DA


Telephone: +44 (0)300 100 0303

Email: [email protected]


Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Offering Circular) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Offering Circular is not addressed.  Prior to relying on the information contained in the Supplement you must ascertain from the Offering Circular whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t